Brevilin A Inhibits STAT3 Signaling and Induces ROS-Dependent Apoptosis, Mitochondrial Stress and Endoplasmic Reticulum Stress in MCF-7 Breast Cancer Cells.
Muhammad Zubair SaleemMuhammad Azhar NisarMohammed AlshwmiSyed Riaz Ud DinYaser GamallatMuhanmmad KhanTonghui MaPublished in: OncoTargets and therapy (2020)
Taken together, Brv-A induces G2/M phase arrest, ROS-dependent apoptosis, ER stress, mitochondrial dysfunction and inhibits STAT3 activation in MCF-7 cells signifying it to be one of the potential anticancer therapeutics in future.